These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 15784621)

  • 1. Regulation of MDR1 expression and drug resistance by a positive feedback loop involving hyaluronan, phosphoinositide 3-kinase, and ErbB2.
    Misra S; Ghatak S; Toole BP
    J Biol Chem; 2005 May; 280(21):20310-5. PubMed ID: 15784621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration.
    Bourguignon LY; Gilad E; Peyrollier K
    J Biol Chem; 2007 Jul; 282(27):19426-41. PubMed ID: 17493932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronan constitutively regulates activation of COX-2-mediated cell survival activity in intestinal epithelial and colon carcinoma cells.
    Misra S; Obeid LM; Hannun YA; Minamisawa S; Berger FG; Markwald RR; Toole BP; Ghatak S
    J Biol Chem; 2008 May; 283(21):14335-44. PubMed ID: 18326857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway.
    Stoica GE; Franke TF; Moroni M; Mueller S; Morgan E; Iann MC; Winder AD; Reiter R; Wellstein A; Martin MB; Stoica A
    Oncogene; 2003 Sep; 22(39):7998-8011. PubMed ID: 12970748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway.
    Ghatak S; Misra S; Toole BP
    J Biol Chem; 2002 Oct; 277(41):38013-20. PubMed ID: 12145277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression.
    Bourguignon LY; Singleton PA; Zhu H; Diedrich F
    J Biol Chem; 2003 Aug; 278(32):29420-34. PubMed ID: 12748184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronan constitutively regulates ErbB2 phosphorylation and signaling complex formation in carcinoma cells.
    Ghatak S; Misra S; Toole BP
    J Biol Chem; 2005 Mar; 280(10):8875-83. PubMed ID: 15632176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronan activates cell motility of v-Src-transformed cells via Ras-mitogen-activated protein kinase and phosphoinositide 3-kinase-Akt in a tumor-specific manner.
    Sohara Y; Ishiguro N; Machida K; Kurata H; Thant AA; Senga T; Matsuda S; Kimata K; Iwata H; Hamaguchi M
    Mol Biol Cell; 2001 Jun; 12(6):1859-68. PubMed ID: 11408591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells.
    Liu F; Liu S; He S; Xie Z; Zu X; Jiang Y
    Oncol Rep; 2010 May; 23(5):1469-75. PubMed ID: 20372866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heregulin-beta1 regulates the estrogen receptor-alpha gene expression and activity via the ErbB2/PI 3-K/Akt pathway.
    Stoica GE; Franke TF; Wellstein A; Morgan E; Czubayko F; List HJ; Reiter R; Martin MB; Stoica A
    Oncogene; 2003 Apr; 22(14):2073-87. PubMed ID: 12687010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
    Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
    Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methyl-beta-cyclodextrin suppresses hyaluronan synthesis by down-regulation of hyaluronan synthase 2 through inhibition of Akt.
    Kultti A; Kärnä R; Rilla K; Nurminen P; Koli E; Makkonen KM; Si J; Tammi MI; Tammi RH
    J Biol Chem; 2010 Jul; 285(30):22901-10. PubMed ID: 20501660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the phosphatidylinositol 3-kinase/Akt pathway prevents radiation-induced apoptosis in breast cancer cells.
    Söderlund K; Pérez-Tenorio G; Stål O
    Int J Oncol; 2005 Jan; 26(1):25-32. PubMed ID: 15586221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells.
    Bourguignon LY; Spevak CC; Wong G; Xia W; Gilad E
    J Biol Chem; 2009 Sep; 284(39):26533-46. PubMed ID: 19633292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
    Gu J; Fang X; Hao J; Sha X
    Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of human MDR1 gene expression by 2-acetylaminofluorene is mediated by effectors of the phosphoinositide 3-kinase pathway that activate NF-kappaB signaling.
    Kuo MT; Liu Z; Wei Y; Lin-Lee YC; Tatebe S; Mills GB; Unate H
    Oncogene; 2002 Mar; 21(13):1945-54. PubMed ID: 11960367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of multidrug resistance in cancer cells by hyaluronan.
    Misra S; Ghatak S; Zoltan-Jones A; Toole BP
    J Biol Chem; 2003 Jul; 278(28):25285-8. PubMed ID: 12738783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the phosphoinositide 3-kinase/Akt signaling pathway in the resistance to therapeutic treatments of human leukemias.
    Martelli AM; Tabellini G; Bortul R; Tazzari PL; Cappellini A; Billi AM; Cocco L
    Histol Histopathol; 2005 Jan; 20(1):239-52. PubMed ID: 15578442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ErbB (HER) receptors can abrogate antiestrogen action in human breast cancer by multiple signaling mechanisms.
    Kurokawa H; Arteaga CL
    Clin Cancer Res; 2003 Jan; 9(1 Pt 2):511S-5S. PubMed ID: 12538508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated expression of erbB3 confers paclitaxel resistance in erbB2-overexpressing breast cancer cells via upregulation of Survivin.
    Wang S; Huang X; Lee CK; Liu B
    Oncogene; 2010 Jul; 29(29):4225-36. PubMed ID: 20498641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.